Stocks · Technology · Laboratory Analytical Instruments

EyePoint, Inc.

EYPT Clue Score33
United States Fiscal year ends December CIK 0001314102 Results filed 19 Oct 2026

What the insiders did Balanced

Insider
Date
Role
Action
Shares
Price
Amount
Ramiro Ribeiro
30 Jun 2026
Chief Medical Officer
Sold after exercise
2,438
$15.02
$36.61K
Ramiro Ribeiro
30 Jun 2026
Chief Medical Officer
Sold after exercise
2,437
$15.00
$36.56K
Ramiro Ribeiro
17 Apr 2026
Chief Medical Officer
Sold after exercise
2,437
$15.00
$36.56K
Ramiro Ribeiro
4 Mar 2026
Chief Medical Officer
Sold after exercise
2,438
$17.87
$43.57K
Ramiro Ribeiro
17 Feb 2026
Chief Medical Officer
Sold after exercise
2,437
$15.00
$36.56K
Ramiro Ribeiro
5 Jan 2026
Chief Medical Officer
Sold after exercise
42,544
$17.10
$727.32K
David R Guyer
12 Jul 2024
Director
Sold after exercise
11,625
$10.06
$117.00K
David R Guyer
3 Jun 2024
Director
Sold after exercise
11,625
$10.30
$119.70K
David R Guyer
14 May 2024
Director
Sold after exercise
11,625
$12.65
$147.04K
David Scott Jones
2 Feb 2024
SVP & Chief Commercial Officer
Sold after exercise
209
$28.49
$5.95K
David Scott Jones
26 Jan 2024
SVP & Chief Commercial Officer
Sold after exercise
9,604
$25.27
$242.72K
David Scott Jones
26 Jan 2024
SVP & Chief Commercial Officer
Sold after exercise
16,413
$25.45
$417.65K
Dario A. Paggiarino
26 Jan 2024
Chief Medical Officer
Sold after exercise
33,665
$25.77
$867.67K
Dario A. Paggiarino
26 Jan 2024
Chief Medical Officer
Sold after exercise
15,609
$25.41
$396.57K
Dario A. Paggiarino
26 Jan 2024
Chief Medical Officer
Sold after exercise
51
$25.41
$1.30K
David Scott Jones
25 Jan 2024
SVP & Chief Commercial Officer
Sold after exercise
300
$25.00
$7.50K
David Scott Jones
25 Jan 2024
SVP & Chief Commercial Officer
Sold after exercise
300
$25.00
$7.50K
Dario A. Paggiarino
25 Jan 2024
Chief Medical Officer
Sold after exercise
300
$25.00
$7.50K
Dario A. Paggiarino
25 Jan 2024
Chief Medical Officer
Sold after exercise
300
$25.00
$7.50K
Dario A. Paggiarino
24 Jan 2024
Chief Medical Officer
Sold after exercise
5,651
$25.02
$141.36K
Dario A. Paggiarino
24 Jan 2024
Chief Medical Officer
Sold after exercise
5,600
$25.01
$140.05K
David Scott Jones
24 Jan 2024
SVP & Chief Commercial Officer
Sold after exercise
5,600
$25.01
$140.07K
David Scott Jones
24 Jan 2024
SVP & Chief Commercial Officer
Sold after exercise
5,700
$25.01
$142.55K
David Scott Jones
23 Jan 2024
SVP & Chief Commercial Officer
Sold after exercise
500
$25.00
$12.50K
David Scott Jones
23 Jan 2024
SVP & Chief Commercial Officer
Sold after exercise
400
$25.00
$10.00K
Dario A. Paggiarino
23 Jan 2024
Chief Medical Officer
Sold after exercise
3,096
$25.00
$77.40K
Dario A. Paggiarino
23 Jan 2024
Chief Medical Officer
Sold after exercise
2,039
$25.00
$50.98K
David Scott Jones
22 Jan 2024
SVP & Chief Commercial Officer
Sold after exercise
28,750
$22.69
$652.25K
David Scott Jones
22 Jan 2024
SVP & Chief Commercial Officer
Sold after exercise
5,416
$22.24
$120.44K
Dario A. Paggiarino
8 Jan 2024
Chief Medical Officer
Sold after exercise
22,913
$21.13
$484.12K
Dario A. Paggiarino
13 Dec 2023
Chief Medical Officer
Sold after exercise
1,458
$20.00
$29.16K
Dario A. Paggiarino
4 Dec 2023
Chief Medical Officer
Sold after exercise
30,625
$22.00
$673.75K
Michael Craig Pine
4 Dec 2023
Chief Corp Dev.&Strat. Officer
Sold after exercise
45,000
$22.00
$990.00K

What was left out

Form 4 filings counted 312
Amendments (4/A) skipped 6
Filings about a different issuer 0
Unreadable filings 0
Joint filings 13
Sales on a Rule 10b5-1 plan 7
Sales straight out of an exercise 33
Sales at will 22
Transactions with no price 0
Shares from compensation/vesting 3,676,102
Sales filed before the plan box existed 1
History held since 22 Oct 2007